Curative Stem Cell Transplantation for Severe Hb H Disease Manifesting From Early Infancy: Phenotypic and Genotypic Analyses

References

• Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011;364(8):710–718
   PubMed Web of Science ®Google Scholar
• Laosombat V, Viprakasit V, Chotsampancharoen T, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88(12):1185–1192
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Cohen A, Porter J, et al., Eds. Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). Nicosia, Cyprus: Thalassaemia International Federation, 2014
   Google Scholar
• Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):150–151
   Web of Science ®Google Scholar
• Eng B, Patterson M, Walker L, et al. Detection of severe nondeletional α-thalassemia mutations using a single-tube multiplex ARMS assay. Genet Test. 2001;5(4):327–329
   PubMedGoogle Scholar
• Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989;17(7):2503–2516
   PubMed Web of Science ®Google Scholar
• So CC, Liu AK, Tsang MH, et al. Genetic basis of persistent red blood cell microcytosis in the Chinese unexplained by phenotypical testing. J Clin Pathol. 2015;68(1):69–72
   PubMed Web of Science ®Google Scholar
• Tachavanich K, Viprakasit V, Pung-Amritt P, et al. Development of a comprehensive red blood cell enzymopathy laboratory in Thailand: The study of normal activity in eight erythroenzymes in Thais. Southeast Asian J Trop Med Public Health. 2009;40(2):317–326
   PubMed Web of Science ®Google Scholar
• Tachavanich K, Tanphaichitr VS, Utto W, Viprakasit V. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders. Southeast Asian J Trop Med Public Health. 2009;40(3):570–575
   PubMed Web of Science ®Google Scholar
• Laosombat V, Fucharoen S, Wiriyasateinkul A. Interaction of the α2 polyadenylation signal mutation (AATAAA→AATA− −) and α0-thalassemia (− −SEA), resulting in Hb H disease in a Thai patient. Hemoglobin. 2001;25(4):383–389
   PubMed Web of Science ®Google Scholar
• Yüregir GT, Aksoy K, Cürük MA, et al. Hb H disease in a Turkish family resulting from the interaction of a deletional α-thalassaemia-1 and a newly discovered poly A mutation. Br J Haematol. 1992;80(4):527–532
   PubMed Web of Science ®Google Scholar
• Harteveld CL, Losekoot M, Haak H, et al. A novel polyadenylation signal mutation in the α2-globin gene causing α thalassaemia. Br J Haematol. 1994;87(1):139–143
   PubMed Web of Science ®Google Scholar
• Hall GW, Higgs DR, Murphy P, et al. A mutation in the polyadenylation signal of the α2 globin gene (AATAAA→AATA− −) as a cause of α thalassaemia in Asian indians. Br J Haematol. 1994;88(1):225–227
   PubMed Web of Science ®Google Scholar
• Prior JF, Lim E, Lingam N, et al. A moderately severe α-thalassemia condition resulting from a combination of the α2 polyadenylation signal (AATAAA→AATA− −) mutation and a 3.7 kb α gene deletion in an Australian family. Hemoglobin. 2007;31(2):173–177
   PubMed Web of Science ®Google Scholar
• Bhattacharya G, Sarkar AA, Banerjee D, et al. Polymerase chain reaction-based search for two α-globin gene mutations in India. Hemoglobin. 2008;32(5):485–490
   PubMed Web of Science ®Google Scholar
• Nair SB, Nadkarni AH, Ghosh K, Colah RB. Variable presentation of Hb H disease due to homozygosity for the rare polyadenylation signal A TIndian (AATAAA > AATA− −) mutation in four Indian families. Hemoglobin. 2013;37(3):277–284
   PubMed Web of Science ®Google Scholar
• Tanphaichitr VS, Suvatte V, Mahasandana C, et al. Pyruvate kinase deficiency in an α-thalassemia family: First case report in Thailand. Southeast Asian J Trop Med Public Health. 1997;28(Suppl 3):64–68
   PubMedGoogle Scholar
• Tanphaichitr VS, Suvatte V, Issaragrisil S, et al. Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency. Bone Marrow Transplant. 2000;26(6):689–690
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Ekwattanakit S, Chalaow N, et al. Clinical presentation and molecular identification of four uncommon α globin variants in Thailand. Initiation codon mutation of α2-globin gene (HBA2:c.1delA), donor splice site mutation of α1-globin gene (IVS-I-1, HBA1:c.95 + 1G > A), Hemoglobin Queens Park/Chao Pra Ya (HBA1:c.98T > A) and Hemoglobin Westmead (HBA2:c.369C > G). Acta Haematol. 2014;131(2):88–94
   PubMed Web of Science ®Google Scholar
• Taher AT, Radwan A, Viprakasit V. When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia. Vox Sang. 2015;108(1):1–10
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Ekwattanakit S, Riolueang S, et al. Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood. 2014;123(10):1586–1595
   PubMed Web of Science ®Google Scholar
• Wajcman H, Vasseur C, Pissard S, et al. α-Hemoglobin stabilizing protein: A modulating factor in thalassemias? Hemoglobin. 2011;35(5-6):463–468
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Viprakasit V. Hb H disease: Clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program. 2009:26–34
   PubMedGoogle Scholar
• Sanpakit K, Viprakasit V. Variable genotype-phenotype correlations in patients with a rare nondeletional α-thalassemia; Hb Pak Num Po (HBA1: c.396_397insT). J Pediatr Hematol Oncol. 2014;36(3):e185–e189
   PubMed Web of Science ®Google Scholar
• Sabloff M, Chandy M, Wang Z, et al. HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood. 2011;117(5):1745–1750
   PubMed Web of Science ®Google Scholar
• Mathews V, George B, Deotare U, et al. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with β thalassemia major undergoing a matched related allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2007;13(8):889–894
   PubMed Web of Science ®Google Scholar
• Anurathapan U, Pakakasama S, Mekjaruskul P, et al. Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification. Biol Blood Marrow Transplant. 2014;20(12):2066–2071
   PubMed Web of Science ®Google Scholar